172 related articles for article (PubMed ID: 37996402)
1. Evaluation of circulating plasma proteins in breast cancer using Mendelian randomisation.
Mälarstig A; Grassmann F; Dahl L; Dimitriou M; McLeod D; Gabrielson M; Smith-Byrne K; Thomas CE; Huang TH; Forsberg SKG; Eriksson P; Ulfstedt M; Johansson M; Sokolov AV; Schiöth HB; Hall P; Schwenk JM; Czene K; Hedman ÅK
Nat Commun; 2023 Nov; 14(1):7680. PubMed ID: 37996402
[TBL] [Abstract][Full Text] [Related]
2. Novel Causal Plasma Proteins for Hypothyroidism: A Large-scale Plasma Proteome Mendelian Randomization Analysis.
Yang H; Chen L; Liu Y
J Clin Endocrinol Metab; 2023 Jan; 108(2):433-442. PubMed ID: 36190832
[TBL] [Abstract][Full Text] [Related]
3. Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis.
Yarmolinsky J; Bouras E; Constantinescu A; Burrows K; Bull CJ; Vincent EE; Martin RM; Dimopoulou O; Lewis SJ; Moreno V; Vujkovic M; Chang KM; Voight BF; Tsao PS; Gunter MJ; Hampe J; Pellatt AJ; Pharoah PDP; Schoen RE; Gallinger S; Jenkins MA; Pai RK; ; ; Gill D; Tsilidis KK
Diabetologia; 2023 Aug; 66(8):1481-1500. PubMed ID: 37171501
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial related genome-wide Mendelian randomization identifies putatively causal genes for multiple cancer types.
Li Y; Sundquist K; Zhang N; Wang X; Sundquist J; Memon AA
EBioMedicine; 2023 Feb; 88():104432. PubMed ID: 36634566
[TBL] [Abstract][Full Text] [Related]
5. Mendelian randomisation analysis of circulating adipokines and C-reactive protein on breast cancer risk.
Robinson T; Martin RM; Yarmolinsky J
Int J Cancer; 2020 Sep; 147(6):1597-1603. PubMed ID: 32134113
[TBL] [Abstract][Full Text] [Related]
6. Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases.
Zheng J; Haberland V; Baird D; Walker V; Haycock PC; Hurle MR; Gutteridge A; Erola P; Liu Y; Luo S; Robinson J; Richardson TG; Staley JR; Elsworth B; Burgess S; Sun BB; Danesh J; Runz H; Maranville JC; Martin HM; Yarmolinsky J; Laurin C; Holmes MV; Liu JZ; Estrada K; Santos R; McCarthy L; Waterworth D; Nelson MR; Smith GD; Butterworth AS; Hemani G; Scott RA; Gaunt TR
Nat Genet; 2020 Oct; 52(10):1122-1131. PubMed ID: 32895551
[TBL] [Abstract][Full Text] [Related]
7. Rho GTPase gene expression and breast cancer risk: a Mendelian randomization analysis.
Kazmi N; Robinson T; Zheng J; Kar S; Martin RM; Ridley AJ
Sci Rep; 2022 Jan; 12(1):1463. PubMed ID: 35087170
[TBL] [Abstract][Full Text] [Related]
8. The relationship between circulating lipids and breast cancer risk: A Mendelian randomization study.
Johnson KE; Siewert KM; Klarin D; Damrauer SM; ; Chang KM; Tsao PS; Assimes TL; Maxwell KN; Voight BF
PLoS Med; 2020 Sep; 17(9):e1003302. PubMed ID: 32915777
[TBL] [Abstract][Full Text] [Related]
9. Mendelian randomization and genetic colocalization infer the effects of the multi-tissue proteome on 211 complex disease-related phenotypes.
Yang C; Fagan AM; Perrin RJ; Rhinn H; Harari O; Cruchaga C
Genome Med; 2022 Dec; 14(1):140. PubMed ID: 36510323
[TBL] [Abstract][Full Text] [Related]
10. Novel Drug Targets for Ischemic Stroke Identified Through Mendelian Randomization Analysis of the Blood Proteome.
Chong M; Sjaarda J; Pigeyre M; Mohammadi-Shemirani P; Lali R; Shoamanesh A; Gerstein HC; Paré G
Circulation; 2019 Sep; 140(10):819-830. PubMed ID: 31208196
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide association study meta-analysis identifies three novel loci for circulating anti-Müllerian hormone levels in women.
Verdiesen RMG; van der Schouw YT; van Gils CH; Verschuren WMM; Broekmans FJM; Borges MC; Gonçalves Soares AL; Lawlor DA; Eliassen AH; Kraft P; Sandler DP; Harlow SD; Smith JA; Santoro N; Schoemaker MJ; Swerdlow AJ; Murray A; Ruth KS; Onland-Moret NC
Hum Reprod; 2022 May; 37(5):1069-1082. PubMed ID: 35274129
[TBL] [Abstract][Full Text] [Related]
12. Genetics of Circulating Resistin Level, a Biomarker for Cardiovascular Diseases, Is Informed by Mendelian Randomization and the Unique Characteristics of African Genomes.
Meeks KAC; Doumatey AP; Bentley AR; Gouveia MH; Chen G; Zhou J; Lei L; Adeyemo AA; Rotimi CN
Circ Genom Precis Med; 2020 Oct; 13(5):488-503. PubMed ID: 32876488
[TBL] [Abstract][Full Text] [Related]
13. Mendelian randomization analyses of 23 known and suspected risk factors and biomarkers for breast cancer overall and by molecular subtypes.
Chen F; Wen W; Long J; Shu X; Yang Y; Shu XO; Zheng W
Int J Cancer; 2022 Aug; 151(3):372-380. PubMed ID: 35403707
[TBL] [Abstract][Full Text] [Related]
14. Proteome-Wide Mendelian Randomization Identifies Causal Links Between Blood Proteins and Acute Pancreatitis.
Bourgault J; Abner E; Manikpurage HD; Pujol-Gualdo N; Laisk T; ; Gobeil É; Gagnon E; Girard A; Mitchell PL; Thériault S; Esko T; Mathieu P; Arsenault BJ
Gastroenterology; 2023 May; 164(6):953-965.e3. PubMed ID: 36736436
[TBL] [Abstract][Full Text] [Related]
15. Modifiable pathways for colorectal cancer: a mendelian randomisation analysis.
Cornish AJ; Law PJ; Timofeeva M; Palin K; Farrington SM; Palles C; Jenkins MA; Casey G; Brenner H; Chang-Claude J; Hoffmeister M; Kirac I; Maughan T; Brezina S; Gsur A; Cheadle JP; Aaltonen LA; Tomlinson I; Dunlop MG; Houlston RS
Lancet Gastroenterol Hepatol; 2020 Jan; 5(1):55-62. PubMed ID: 31668584
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Targets for Heart Failure Identified Using Proteomics and Mendelian Randomization.
Henry A; Gordillo-Marañón M; Finan C; Schmidt AF; Ferreira JP; Karra R; Sundström J; Lind L; Ärnlöv J; Zannad F; Mälarstig A; Hingorani AD; Lumbers RT;
Circulation; 2022 Apr; 145(16):1205-1217. PubMed ID: 35300523
[TBL] [Abstract][Full Text] [Related]
17. Circulating inflammatory cytokines and risk of five cancers: a Mendelian randomization analysis.
Bouras E; Karhunen V; Gill D; Huang J; Haycock PC; Gunter MJ; Johansson M; Brennan P; Key T; Lewis SJ; Martin RM; Murphy N; Platz EA; Travis R; Yarmolinsky J; Zuber V; Martin P; Katsoulis M; Freisling H; Nøst TH; Schulze MB; Dossus L; Hung RJ; Amos CI; Ahola-Olli A; Palaniswamy S; Männikkö M; Auvinen J; Herzig KH; Keinänen-Kiukaanniemi S; Lehtimäki T; Salomaa V; Raitakari O; Salmi M; Jalkanen S; ; Jarvelin MR; Dehghan A; Tsilidis KK
BMC Med; 2022 Jan; 20(1):3. PubMed ID: 35012533
[TBL] [Abstract][Full Text] [Related]
18. Potential drug targets for multiple sclerosis identified through Mendelian randomization analysis.
Lin J; Zhou J; Xu Y
Brain; 2023 Aug; 146(8):3364-3372. PubMed ID: 36864689
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Targets for Diabetic Kidney Disease: Proteome-Wide Mendelian Randomization and Colocalization Analyses.
Zhang W; Ma L; Zhou Q; Gu T; Zhang X; Xing H
Diabetes; 2024 Apr; 73(4):618-627. PubMed ID: 38211557
[TBL] [Abstract][Full Text] [Related]
20. A Mendelian randomization analysis of circulating lipid traits and breast cancer risk.
Beeghly-Fadiel A; Khankari NK; Delahanty RJ; Shu XO; Lu Y; Schmidt MK; Bolla MK; Michailidou K; Wang Q; Dennis J; Yannoukakos D; Dunning AM; Pharoah PDP; Chenevix-Trench G; Milne RL; Hunter DJ; Per H; Kraft P; Simard J; Easton DF; Zheng W
Int J Epidemiol; 2020 Aug; 49(4):1117-1131. PubMed ID: 31872213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
